Libidon: clinical report reproduced in the Russian institute-report collection (2011)
Medical Center, St Petersburg Institute of Bioregulation and Gerontology (attributed in reproduction) · 2011 · Commercial brochure, PDF pages 47–50; institute original unauthenticated
What does this source report?
The report describes adjunctive Libidon alongside usual treatment and reports improved urinary symptoms and flow measures. Reported significance is mainly against baseline, so it does not establish superiority to usual treatment.
- Population and setting
- 48 treated men aged 38–65 (28 chronic prostatitis, 20 benign prostatic hyperplasia); 22 controls described separately; full denominator reconciliation pending
- Evidence type
- Human comparative study
- Preparation
- Prostate-derived peptide mixture
- Source language
- Russian
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- The signed original and protocol have not been authenticated.
- Allocation and blinding are not established; diagnostic subgroups, 22 separately described controls and symptom-specific denominators require reconciliation.
- Concurrent treatment prevents attribution to Libidon alone. No equivalence to Prostatilen or Prostamax is established.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Document format: Russian PDF brochure
Review depth: Text-level methods check; original and table verification pending
Source access and review scope
Russian brochure text, preparation description and group narrative checked. Visual table verification and original-report authentication remain pending.
Recorded source-check date: 2026-10-06. This date does not imply a completed systematic review.
Source provenance: Institute report — commercial reproduction
Cite and trace this record
Original source: Medical Center, St Petersburg Institute of Bioregulation and Gerontology (attributed in reproduction). Libidon: clinical report reproduced in the Russian institute-report collection (2011) Commercial brochure, PDF pages 47–50; institute original unauthenticated 2011.
Molekul research summary: https://molekul.io/research/audit-libidon-report-2011. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry